Comparison of the 1999 Sapporo and 2006 revised criteria for the classification of the antiphospholipid syndrome
- PMID: 20149305
Comparison of the 1999 Sapporo and 2006 revised criteria for the classification of the antiphospholipid syndrome
Abstract
Objectives: The 2006 revised criteria for antiphospholipid syndrome (APS) provide a new classification challenge, and studies validating the updated criteria against the older ones are still scanty. We compared the 1999 preliminary with the 2006 revised classification criteria for APS, and evaluated if the revised criteria provide an added value over the original ones.
Methods: A laboratory-based registry population was obtained on the basis of the positivity of antiphospholipid (aPL) antibodies. Patients were analysed for fulfillment of the 1999 and 2006 classification criteria for APS, non-criteria features of APS, and autoantibody profile.
Results: Of 144 aPL-positive identified patients, 119 had at least 2 aPL tests on separated occasions, and were included in this study. According to the 1999 criteria, 23 patients had APS (15 had thrombosis alone, 4 pregnancy morbidity, and 4 both); while 26 fulfilled the 2006 revised criteria (15 had thrombosis alone, 5 pregnancy morbidity, and 6 both). One patient with isolated thrombosis who met 1999 criteria did not meet those of 2006 (aCL positivity but not >12 weeks apart). One patient with thrombosis, other with pregnancy morbidity, and 2 with both only fulfilled the 2006 criteria because they had isolated anti-Beta(2)GPI antibody-positivity. High concordance between criteria was found, with kappa index of 0.87 (95%; CI, 0.76-0.98).
Conclusions: The 2006 revised criteria represent a step-forward since it allows the inclusion of patients with anti-Beta(2)GPI antibodies as an isolated serological feature. However, a wider time interval between serologic tests seems unlikely to make differences.
Similar articles
-
Assessment of the 2006 revised antiphospholipid syndrome classification criteria.Ann Rheum Dis. 2007 Jul;66(7):927-30. doi: 10.1136/ard.2006.067314. Epub 2007 Mar 2. Ann Rheum Dis. 2007. PMID: 17337473 Free PMC article.
-
Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.Arthritis Rheumatol. 2015 May;67(8):2196-204. doi: 10.1002/art.39187. Arthritis Rheumatol. 2015. PMID: 25939498
-
Antiphospholipid-associated thrombocytopenia or autoimmune hemolytic anemia in patients with or without definite primary antiphospholipid syndrome according to the Sapporo revised classification criteria: a 6-year follow-up study.Blood. 2010 Oct 21;116(16):3058-63. doi: 10.1182/blood-2010-05-283507. Epub 2010 Jul 12. Blood. 2010. PMID: 20625007
-
Diagnosis and classification of the antiphospholipid syndrome.J Autoimmun. 2014 Feb-Mar;48-49:20-5. doi: 10.1016/j.jaut.2014.01.006. Epub 2014 Jan 24. J Autoimmun. 2014. PMID: 24461539 Review.
-
What have we learned about antiphospholipid syndrome from patients and antiphospholipid carrier cohorts?Semin Thromb Hemost. 2012 Jun;38(4):322-7. doi: 10.1055/s-0032-1304719. Epub 2012 Mar 7. Semin Thromb Hemost. 2012. PMID: 22399307 Review.
Cited by
-
Clinical Application of Revised Laboratory Classification Criteria for Antiphospholipid Antibody Syndrome: Is the Follow-Up Interval of 12 Weeks Instead of 6 Weeks Significantly Useful?Biomed Res Int. 2016;2016:2641526. doi: 10.1155/2016/2641526. Epub 2016 Aug 17. Biomed Res Int. 2016. PMID: 27610369 Free PMC article.
-
Retrospective Evaluation of New Chinese Diagnostic Scoring System for Disseminated Intravascular Coagulation.PLoS One. 2015 Jun 15;10(6):e0129170. doi: 10.1371/journal.pone.0129170. eCollection 2015. PLoS One. 2015. PMID: 26076032 Free PMC article.
-
The 2023 ACR/EULAR antiphospholipid syndrome classification criteria identify patients at high risk of complications.Clin Rheumatol. 2024 Nov;43(11):3373-3377. doi: 10.1007/s10067-024-07144-7. Epub 2024 Sep 18. Clin Rheumatol. 2024. PMID: 39294500
-
A Simplified Understanding of the Black Swan: Anti-phospholipid Antibody Syndrome.JNMA J Nepal Med Assoc. 2019 Mar-Apr;57(216):133-145. doi: 10.31729/jnma.4226. JNMA J Nepal Med Assoc. 2019. PMID: 31477950 Free PMC article. Review.
-
Diagnostic and Prognostic Value of Plasma Factor V Activity and Parameters in Thrombin Generation for Disseminated Intravascular Coagulation in Patients with Hematological Malignancies.Curr Med Sci. 2019 Aug;39(4):546-550. doi: 10.1007/s11596-019-2072-9. Epub 2019 Jul 25. Curr Med Sci. 2019. PMID: 31346989
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous